Sector note · Healthcare
Healthcare: specialists buy in, owners stay on
Foreign healthcare groups buy Turkish specialists, from dialysis products to fertility clinics, and often keep the people who built them in the business; hospitals are bought by groups already running hospitals in Turkey.
Named deals
- 1Proklinik Ottobock · 51%, August 2023
- 2R-Vent Medikal Plastiflex · November 2023; the managing director reinvested
- 3Farmasol Pollet Medical Group · majority, January 2025
- 4Bahçeci FutureLife · joint control with the family, April 2025
- 5Samsun Medikal Grup MLP Sağlık · the last 20% for USD 115m, September 2026
- 01
Since January 2023, foreign buyers took part in 21 of the 76 Turkish healthcare transactions in Orion’s register; in 17 of those the buyer was a company in the same business rather than a fund.
Orion Capital Partners register, January 2023 to September 2026
- 02
FutureLife, a fertility group with clinics across Europe and, at the time, no business in Turkey, agreed in April 2025 to share control of Bahçeci’s IVF centres with the Bahçeci family; the family keeps a seat on the board, and the annual budget needs its director’s vote.
- 03
Belgium’s Pollet Medical Group bought a majority of Farmasol, a Kayseri maker of disposable dialysis products, which joined the group in January 2025; Farmasol’s shareholders and management team stay on.
- 04
Plastiflex agreed in November 2023 to buy R-Vent Medikal, an Izmir medical device company; its managing director, one of the shareholders, stayed in place and reinvested in the Plastiflex Group.
- 05
Hospitals are bought by groups already running hospitals in Turkey: MLP Sağlık (Medical Park) bought the remaining 20% of Samsun Medikal Grup, which runs seven hospitals, from the other shareholders for USD 115m in cash in September 2026, taking sole control.
Orion view
A foreign specialist buys a product, a licence or a clinical team it cannot build quickly in Turkey, and usually wants the people behind it to stay. Your role after the sale is then part of the price: what you run, what you can veto, and when the rest of your shares are bought. Agree those terms with the headline value. Hospitals have a smaller circle of buyers, so the order in which you approach them matters.
Sources: as cited above, read October 2026; Orion Capital Partners analysis.
Start with a conversation.
A first conversation is confidential and carries no obligation.